Vyome Holdings (HIND) Net Margin (QoQ) (2015 - 2026)
Vyome Holdings (HIND) Net Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30,383.00 |
| Mar 31, 2026 | -24,521.00 |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | -2.46 Mn |
| Jun 30, 2025 | -95,402.00 |
| Mar 31, 2025 | 360,904.00 |
| Dec 31, 2024 | -99,634.00 |
| Sep 30, 2024 | -178,926.00 |
| Jun 30, 2024 | 3,164.00 |
| Mar 31, 2024 | -2,714.00 |
| Dec 31, 2023 | 7,832.00 |
| Sep 30, 2023 | -902.00 |
| Jun 30, 2023 | -3,857.00 |
| Mar 31, 2023 | 41,315.00 |
| Dec 31, 2022 | -9,402.00 |
| Sep 30, 2022 | -10,897.00 |
| Jun 30, 2022 | 603.00 |
| Sep 30, 2021 | -35,188.00 |
| Jun 30, 2021 | 4,112.00 |
| Mar 31, 2021 | 11,485.00 |